Successful allogeneic fecal microbiota transplantation for severe diversion colitis: a case report
- PMID: 38749910
- PMCID: PMC11107325
- DOI: 10.1177/03000605241241000
Successful allogeneic fecal microbiota transplantation for severe diversion colitis: a case report
Abstract
Ileostomy diverts the flow of feces, which can result in malnutrition in the distal part of the intestine. The diversity of the gut microbiota consequently decreases, ultimately leading to intestinal dysbiosis and dysfunction. This condition can readily result in diversion colitis (DC). Potential treatment strategies include interventions targeting the gut microbiota. In this case study, we effectively treated a patient with severe DC by ileostomy and allogeneic fecal microbiota transplantation (FMT). A 69-year-old man presented with a perforated malignant tumor in the descending colon and an iliac abscess. He underwent laparoscopic radical sigmoid colon tumor resection and prophylactic ileostomy. Follow-up colonoscopy 3 months postoperatively revealed diffuse intestinal mucosal congestion and edema along with granular inflammatory follicular hyperplasia, leading to a diagnosis of severe DC. After two rounds of allogeneic FMT, both the intestinal mucosal bleeding and edema significantly improved, as did the diversity of the gut microbiota. The positive outcome of allogeneic FMT in this case highlights the potential advantages that this procedure can offer patients with DC. However, few studies have focused on allogeneic FMT, and more in-depth research is needed to gain a better understanding.
Keywords: Diversion colitis; case report; colonic tumor; enterostomy; fecal microbiota transplantation; gut microbiota.
Conflict of interest statement
Declaration of conflicting interestYong-Ling Lv, Kai Xiong, and Zhi-Wei Jiang are employees of Maintainbiotech, Ltd. (Wuhan, China). The other authors declare no conflict of interest.
Figures





Similar articles
-
Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.J Physiol Pharmacol. 2016 Dec;67(6):859-866. J Physiol Pharmacol. 2016. PMID: 28195066
-
Fecal microbiota transplantation induces remission of infantile allergic colitis through gut microbiota re-establishment.World J Gastroenterol. 2017 Dec 28;23(48):8570-8581. doi: 10.3748/wjg.v23.i48.8570. World J Gastroenterol. 2017. PMID: 29358865 Free PMC article.
-
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.Inflamm Bowel Dis. 2017 Jun;23(6):903-911. doi: 10.1097/MIB.0000000000001132. Inflamm Bowel Dis. 2017. PMID: 28445246 Free PMC article. Clinical Trial.
-
Fecal microbiota transplantation for ulcerative colitis.Immunol Med. 2021 Mar;44(1):30-34. doi: 10.1080/25785826.2020.1792040. Epub 2020 Jul 14. Immunol Med. 2021. PMID: 32663072 Review.
-
An updated review on the treatment for diversion colitis and pouchitis, with a focus on the utility of autologous fecal microbiota transplantation and its relationship with the intestinal microbiota.Biosci Microbiota Food Health. 2024;43(3):162-169. doi: 10.12938/bmfh.2024-014. Epub 2024 Apr 23. Biosci Microbiota Food Health. 2024. PMID: 38966047 Free PMC article. Review.
References
-
- Isbert C. Technique of enterostomy. Coloproctology 2019; 41: 324–329.
-
- Galpérine T, Guery B; French Group of Fecal Microbiota Transplantation (GFTF). Exploring ways to improve CDI outcomes. Med Mal Infect 2018; 48: 10–17. - PubMed
-
- Parenteral and Enteral Nutrition Branch of Chinese Medical Association; Enhanced Recovery After Surgery Branch of China International Health Care Promotion and Exchange Association; China Microecological Treatment Innovation Alliance; Microecology Committee of Shanghai Preventive Medicine Association. Chinese experts consensus on standardized methodology and clinical application of fecal microbiota transplantation. Zhonghua Wei Chang Wai Ke Za Zhi 2020; 23: 5–13. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources